Asthma
COPD
Pulmonary
Pulmonary: Page 12
Nerandomilast slows lung function decline in pulmonary fibrosis patients
The investigational drug met the primary endpoint in parallel phase 3 trials but did not meet the secondary endpoint.
June 5, 2025
Boosting immunity with nasal vaccines
The alternative form of immunization could offer increased protection in the respiratory tract.
May 29, 2025
Fresh treatment option for two pulmonary diseases
The FDA’s approval of Yutrepia could help improve quality of life for patients with PAH and PH-ILD.
May 28, 2025
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
The powerful destruction of microplastics
Tiny, inhaled pollutants suppress primary functions of pulmonary macrophages.
May 22, 2025
Alternative pulmonary sarcoidosis therapy
Clinical trial results show methotrexate to be a safe and effective treatment option.
May 22, 2025
A step toward securing successful lung transplant outcomes
Registry data demonstrates drug efficacy to prevent chronic lung allograft dysfunction.
May 15, 2025
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
Alternative antibiotic therapy for severe lung infections
The modified medications may provide new options against drug-resistant bacteria.
May 14, 2025
Cancer drug could complement TB treatments
Mouse model study results show experimental medicine may boost first-line therapy for tuberculosis.
May 8, 2025
New guidance to prevent serious lung infection
The ALA shines light on recent updates to the CDC’s recommendations for pneumococcal vaccination.
May 7, 2025
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
A breakthrough in controlling COVID-19 inflammation
Scientists discover a rare lung immune cell type that helps protect against the deadly disease.
May 2, 2025
Investigational drug zongertinib shows promise in NSCLC patients
The tyrosine kinase inhibitor (TKI) achieved a 71% response rate in clinical trial.
May 2, 2025
Adapted CPAP approach helps preterm infant lung growth, function
Clinical trial results demonstrate safe and effective breathing therapy to improve early respiratory health.
April 22, 2025
Previous Page
Page 12 of 29
Next Page
Most Popular
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
FDA approves study of inhaled stem cell therapy for COPD
Common cold: There may be a vaccine for that
Semaglutide significantly lowers asthma, COPD attacks
Childhood pollution exposure linked to COPD
Novel inhaled treatment for COPD shows promise in clinical trial